Invizyne Technologies Common StockNASDAQ: IZTC

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$106.55 M
0%vs. 3y high
46%vs. sector
-vs. 3y high
-vs. sector
-29.59
-51%vs. 3y high
2%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | Wed, 20 Nov 2024 14:30:00 GMT
$13.11+$0.11(+0.85%)

Dividend

No data over the past 3 years
$0.00-$1.66 M

Analysts recommendations

Institutional Ownership

Included in screeners

No data

What type of business is Invizyne Technologies Common Stock?

Invizyne Technologies, Inc. operates as a synthetic biochemical company. Its SimplePath platform produces a range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds, as well as consists of a series of modular cascading enzyme based biomanufacturing systems that natural processes to perform chemical conversions. The company was incorporated in 2019 and is based in Monrovia, California.

What sector is Invizyne Technologies Common Stock in?

Invizyne Technologies Common Stock is in the Healthcare sector

What industry is Invizyne Technologies Common Stock in?

Invizyne Technologies Common Stock is in the Biotechnology industry

What country is Invizyne Technologies Common Stock from?

Invizyne Technologies Common Stock is headquartered in United States

What is Invizyne Technologies Common Stock website?

https://www.invizyne.com

Is Invizyne Technologies Common Stock in the S&P 500?

No, Invizyne Technologies Common Stock is not included in the S&P 500 index

Is Invizyne Technologies Common Stock in the NASDAQ 100?

No, Invizyne Technologies Common Stock is not included in the NASDAQ 100 index

Is Invizyne Technologies Common Stock in the Dow Jones?

No, Invizyne Technologies Common Stock is not included in the Dow Jones index

When was Invizyne Technologies Common Stock the previous earnings report?

No data

When does Invizyne Technologies Common Stock earnings report?

Next earnings report date is not announced yet